trending Market Intelligence /marketintelligence/en/news-insights/trending/zVgfMhqoaq5mlGKtf9FcjA2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Grape King Bio profit misses consensus by 22.4% in Q3


Understanding the Basics of Social Housing Providers and Associations (SHPAs)


Tech in Banking: An Age of Digital Disruption


COVID-19 Impact & Recovery: LCD Outlook for H2 2021


COVID 19 Impact Recovery Media Telecom and Technology Outlook for H2 2021

Grape King Bio profit misses consensus by 22.4% in Q3

Grape King Bio Ltd. said its third-quarter normalized net income was NT$1.23 per share, compared with the S&P Capital IQ consensus estimate of NT$1.59 per share.

EPS climbed 5.2% year over year from NT$1.17.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was NT$164.0 million, an increase of 7.2% from NT$153.0 million in the prior-year period.

The normalized profit margin dropped to 9.5% from 10.1% in the year-earlier period.

Total revenue grew 14.5% year over year to NT$1.73 billion from NT$1.51 billion, and total operating expenses climbed 14.6% on an annual basis to NT$1.27 billion from NT$1.11 billion.

Reported net income grew 6.6% from the prior-year period to NT$262.6 million, or NT$1.98 per share, from NT$246.5 million, or NT$1.89 per share.

As of Nov. 11, US$1 was equivalent to NT$32.72.